UPDATE ON THE TERMS OF THE SHAREHOLDERS GENERAL MEETING
UPDATE ON THE TERMS OF THE SHAREHOLDERS GENERAL MEETING
Nantes, June 9th, 2025, 8 a.m. - OSE Immunotherapeutics SA (ISIN: FR0012127173; Mnemo: OSE) informs its shareholders and the market of the update on the terms of the Combined General Meeting scheduled for 25 June 2025 (the 'General Meeting').
In preparation of the General Meeting, OSE Immunotherapeutics has formally submitted to the President of the Nantes Commercial Court a request to extend the date of the General Meeting.
The purpose of this approach is to ensure that the General Meeting is held in a regular and transparent manner and that shareholders are properly informed. It is in response to requests made by some of the Company's shareholders, in a context marked by the filing, by a group of shareholders acting in concert, of several resolutions aimed at substantially changing the composition of the Board of Directors.
Furthermore, the communication of these resolutions to the market did not occur in a timely manner nor under conditions ensuring, at this stage, that shareholders are fully and fairly informed or that the General Meeting is properly or regularly held.
In this respect, the resolutions presented by the group of shareholders acting in concert and which have not been approved by the Board of directors are not identified clearly enough on the voting form posted on the Company's website on June 4th, 2025.
The Company indicates that the resolutions of this group of shareholders, on which the Board of Directors recommends voting against, are renumbered A to K (instead of resolutions n°35 to 44). Apart from this renumbering, all the resolutions remain unchanged.
An amended convening notice will be published in the official legal bulletin.
The voting form along with the preparatory documents for the General meeting required by Article R. 22-10-23 of the French Commercial Code, as amended to include this renumbering, are available on the Company's website: https://www.ose-immuno.com/assemblees-generales/.
OSE Immunotherapeutics considers that the current situation as described above and in the press release dated June 4th, 2025 raises significant legal uncertainties, which justify referring to the judge to extend the date of the General Meeting in order to secure the voting process and ensure that shareholders are consulted in an orderly fashion.
OSE Immunotherapeutics affirms its determination to protect the interests of all its shareholders and to defend the transparency and integrity of its governance, in compliance with the legal and regulatory framework.
OSE Immunotherapeutics will communicate in due course on the progress of this procedure.
ABOUT OSE IMMUNOTHERAPEUTICS
OSE Immunotherapeutics is a biotech company dedicated to developing first-in-class assets in immuno-oncology (IO) and immuno-inflammation (I&I) that address the unmet patient needs of today and tomorrow. We partner with leading academic institutions and biopharmaceutical companies in our efforts to develop and bring to the market transformative medicines for people with serious diseases. OSE Immunotherapeutics is based between Nantes and Paris and is quoted on Euronext.
Additional information about OSE Immunotherapeutics assets is available on the Company's website: www.ose-immuno.com. Follow us on LinkedIn.
Contacts
Fiona Olivierfiona.olivier@ose-immuno.comSylvie Détrysylvie.detry@ose-immuno.com
French Media Contact FP2COMFlorence Portejoiefportejoie@fp2com.fr+33 6 07 768 283
U.S. Media ContactRooney Partners LLCKate Barrettekbarrette@rooneypartners.com+1 212 223 0561
Forward-looking statementsThis press release contains express or implied information and statements that might be deemed forward-looking information and statements in respect of OSE Immunotherapeutics. They do not constitute historical facts. These information and statements include financial projections that are based upon certain assumptions and assessments made by OSE Immunotherapeutics' management considering its experience and its perception of historical trends, current economic and industry conditions, expected future developments and other factors they believe to be appropriate.
These forward-looking statements include statements typically using conditional and containing verbs such as 'expect', 'anticipate', 'believe', 'target', 'plan', or 'estimate', their declensions and conjugations and words of similar import. Although the OSE Immunotherapeutics management believes that the forward-looking statements and information are reasonable, the OSE Immunotherapeutics' shareholders and other investors are cautioned that the completion of such expectations is by nature subject to various risks, known or not, and uncertainties which are difficult to predict and generally beyond the control of OSE Immunotherapeutics. These risks could cause actual results and developments to differ materially from those expressed in or implied or projected by the forward-looking statements. These risks include those discussed or identified in the public filings made by OSE Immunotherapeutics with the AMF. Such forward-looking statements are not guarantees of future performance. This press release includes only summary information and should be read with the OSE Immunotherapeutics Universal Registration Document filed with the AMF on April 30, 2025, including the annual financial report for the fiscal year 2024, available on the OSE Immunotherapeutics' website. Other than as required by applicable law, OSE Immunotherapeutics issues this press release at the date hereof and does not undertake any obligation to update or revise the forward-looking information or statements.
Attachment
EN_250509_Update GM
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
an hour ago
- Yahoo
Rafale Reemerges With Conformal Fuel Tanks
Dassault has installed conformal fuel tanks, or CFTs, on one of its Rafale multirole fighters, promising a significant improvement in range, while also increasing the aircraft's ability to carry external weapons and stores. While CFTs had previously been tested on the Rafale, the idea has now regained traction, which could have significant ramifications for the French fighter's future capabilities. It could also impact the export prospects for these jets, as well. Rafale avec réservoir fuselage ?Drone UCAV Neuron ?Drone MALE AAROK ?Le Bourget va être incroyable — FR 𝕏 Defense (@FR_Defense) June 11, 2025 The above photo of a two-seat French Air Force Rafale B fitted with CFTs began circulating recently on social media. The tanks are installed on top of the center 'barrel' section of the Rafale's fuselage, fitted on each side of the aircraft's central spine. The aircraft was spotted as part of the static display in the run-up to the Paris Air Show, which begins in the French capital on June 16. Also photographed in the same area were a flying-wing type drone, perhaps the Dassault nEUROn, and the huge Aarok medium-altitude, long-endurance (MALE) drone, which you can read more about here. It's not clear if the Rafale's CFTs are fully workable and plumbed into the aircraft or if they are representative mock-ups. But it's notable that the CFTs have reappeared at a time when rival manufacturers appear to have mainly abandoned plans to offer their fourth-generation fighters with this option. Interestingly, the Rafale B01 prototype was flown with CFTs back in 2001, as seen at the top of this article, but this configuration didn't attract any customers. Since then, according to Dassault, all Rafales have been completed with the option to add CFTs, although it's unclear how much modification work would be required. Rafale with CFTs is back!? Posting photos below from maiden tests of CFTs on Rafale B back in @Dassault_OnAir already mentions that "All Rafales have built-in CFT capability". Pitching it again? — Rishav Gupta (ऋषव गुप्ता) | (@connect_rishav) June 12, 2025 There's no doubt, however, that CFTs offer the Rafale significant benefits in terms of range and performance over draggy drop tanks. Jets with CFTs can also carry additional stores on pylons under the wing and under the fuselage that otherwise would have to be set aside to carry the drop tanks. This latter point is particularly relevant to the Rafale, which is regularly seen loaded with three 330-gallon drop tanks, two under the wings and one under the belly. This restricts the fighter to carrying, for example, six air-to-air missiles (AAMs) or eight in a much more rarely seen overload configuration. When it comes to the critically important Meteor beyond-visual-range AAM, the Rafale can currently carry a maximum of four — CFTs would very likely allow that total to be increased. Currently, magazine depth is very much at a premium in air combat — the ability of an aircraft to carry a considerable number of external weapons. This is something that has been emphasized in recent operations to defeat drones and cruise missiles in the Middle East. Here, at least one U.S. Air Force F-15E — a type generally prized for its magazine depth — exhausted all its AAMs and resorted to using its gun against the low and slow-flying drones. Now, the U.S. Air Force is resorting to arming its fighters with laser-guided rockets to drastically expand magazine depth in this theater. It's not clear how much additional range the CFTs would provide the Rafale, although we have asked Dassault for more details. It's certainly the case, however, that the Rafale, in its basic form, is not well known for its range. By way of comparison, Boeing said, in the past, that an F/A-18E/F Super Hornet carrying two AIM-9X Sidewinders, two AIM-120 Advanced Medium-Range Air-to-Air Missiles (AMRAAM), and two 2,000-pound-class precision-guided bombs would have a combat radius of 594 nautical miles with only the fuel in its internal tanks, plus a drop tank on its centerline pylon. With CFTs, a Super Hornet with the same loadout would have a combat radius of 714 nautical miles. However, plans to include CFTs in the Block III upgrade package for the U.S. Navy's F/A-18E/Fs were dropped after discovering various issues with them during testing. In this case, the problems may well have been related to operating CFT-equipped Super Hornets from aircraft carriers, namely how the reconfigured aircraft handled the stresses of catapult launches and arrested recoveries. In the past, Dassault has said it also offers CFTs on the carrier-capable Rafale M version. Boeing also previously offered Super Hornets with CFTs, notably to Canada (in land-based form) and to India, neither of which opted to buy the aircraft. It's worth noting, too, that CFTs come with very particular disadvantages. Unlike drop tanks, they cannot be jettisoned when required, for example, to enhance agility during a dogfight or during some kind of emergency scenario. They also have their own performance penalty, adding drag and weight even when empty. As it now stands, the Rafale's CFTs appear to be offered again as part of the latest Standard F5 configuration. In an interview with AirForces Monthly magazine in 2023, Guilhem Reboul, then-head of the Rafale program within the Direction Générale de l'Armement (DGA), the French defense procurement agency, said that, for Standard F5, 'Modifications to the airframe are also considered, including the adoption of conformal fuel tanks and of radar-cross-section reduction kits, to increase the stealthiness of the Rafale.' As you can read about here, Standard F5 is planned to keep the Rafale in frontline service until around 2060. This latest iteration of the Rafale will focus on collaborative combat, as well as incorporating new-generation weapons, among them the ASN4G, the next-generation standoff nuclear weapon. Other new weapons for Standard F5 are expected to include successors for the SCALP conventional cruise missile and the Exocet anti-ship missile, with a hypersonic design being examined for the latter requirement. Air-to-air munitions should include an upgraded Meteor beyond-visual-range missile. Very significantly, the F5 version is also planned to be fielded alongside a new, French-developed uncrewed combat air vehicle (UCAV). As well as the aforementioned Super Hornet Block III, CFTs have also been offered in the past for the Eurofighter Typhoon. Eurofighter eventually reported that there was a lack of customer interest in CFTs for Typhoon, although there are unconfirmed reports that there were also aerodynamic problems uncovered during wind tunnel testing. Instead of CFTs, Eurofighter decided to push other range-extending changes, including the Aerodynamic Modification Kit (AMK), which involves adding fuselage strakes and root extensions to increase maximum lift, also improving load-carrying ability and agility. Well, EF said "no customer appetite", but reportedly problems found during wind tunnel testing. The "other ways" noted below include the Aerodynamic Modification Kit of the LTE package. — Gareth Jennings (@GarethJennings3) June 12, 2025 Meanwhile, the F-15 and F-16 have long been successfully operated by multiple different air forces, including on combat operations, with CFTs fitted. CFTs have been an option for F-15-series jets since the 1970s, and the Israeli Air Force was a pioneer in their use, transforming fighters into long-range strike platforms, as you can read more about here. Noteworthy, too, is the fact that, in the case of U.S. Air Force F-15Es, these aircraft are now more regularly having their CFTs removed, specifically to achieve higher performance for certain air-to-air mission sets. With previous test-flight work having been completed on the Rafale, the technical challenges that hampered the introduction of CFTs on the Super Hornet and Typhoon might well be more easily mastered by Dassault. While it remains to be seen whether France or any of the Rafale's growing family of export operators opt for CFTs in the future, the fact that these can apparently be added to any existing Rafale airframe should make this a more attractive proposition. They are also being revisited at a time in which, after significant export success, the Rafale's reputation is somewhat tarnished, whether justifiably or not, by its performance in recent Indian-Pakistan engagements. Keeping the aircraft relevant with new upgrades is more important than ever. Provided they are affordable, the CFTs should offer significant benefits to the Rafale in terms of both range and load-carrying ability, although, as with similar add-ons, they do come with some disadvantages, too. Contact the author: thomas@
Yahoo
an hour ago
- Yahoo
Build-A-Bear Workshop, Inc. Announces Quarterly Cash Dividend
ST. LOUIS, June 12, 2025--(BUSINESS WIRE)--Build-A-Bear Workshop, Inc. (NYSE: BBW) announced today that its Board of Directors declared a quarterly cash dividend of $0.22 per share of issued and outstanding common stock. The dividend will be paid on July 10, 2025, to all stockholders of record as of June 26, 2025. About Build-A-Bear Since its beginning in 1997, Build-A-Bear has evolved to become a beloved multi-generational brand focused on its mission to "add a little more heart to life," where guests of all ages make their own "furry friends" in celebration and commemoration of life moments. Guests create their own stuffed animals by participating in the stuffing, dressing, accessorizing, and naming of their own teddy bears and other plush toys based on the Company's own intellectual property and in conjunction with a variety of best-in-class licenses. The hands-on and interactive nature of our more than 600 company-owned, partner-operated and franchise experience locations around the world, combined with Build-A-Bear's pop-culture appeal, often fosters a lasting and emotional brand connection with consumers and has enabled the Company to expand beyond its retail stores to include e-commerce sales on and non-plush branded consumer categories via out-bound licensing agreements with leading manufacturers, as well as the creation of engaging content via Build-A-Bear Entertainment (a subsidiary of Build-A-Bear Workshop, Inc.). The brand's newest communications campaign, "The Stuff You Love," commemorates more than a quarter-century of creating cherished memories worldwide. Build-A-Bear Workshop, Inc. (NYSE: BBW) posted consolidated total revenues of $496.4 million for fiscal 2024. For more information, visit the Investor Relations section of Forward-Looking Statements: Statements regarding quarterly or future dividends, whether regular or special, payable to the company's shareholders, which may be subject to future increases, decreases, or elimination, as determined by the Build-A-Bear Workshop, Inc. Board of Directors, are forward-looking statements as defined in the Private Securities Litigation Reform Act of 1995. The company cautions investors that any such forward-looking statements are not guarantees of future performance, including but not limited to, growth, earnings improvement, returns, future dividend payments, or the amount of such payments. Investors are directed to consider the risks and uncertainties in the company's business that may cause actual results to differ and/or affect the board's decision to declare dividends in the future, including those factors discussed under the caption entitled "Risk Factors" and "Forward-Looking Statements" in our Annual Report on Form 10-K filed with the Securities and Exchange Commission ("SEC") on April 17, 2025 and other periodic reports filed with the SEC which are incorporated herein. All of our forward-looking statements are as of the date of this Press Release only. In each case, actual results may differ materially from such forward-looking information. We can give no assurance that such expectations or forward-looking statements will prove to be correct. An occurrence of or any material adverse change in one or more of the risk factors or other risks and uncertainties referred to in this Press Release or included in our other public disclosures or our other periodic reports or other documents or filings filed with or furnished to the SEC could materially and adversely affect our continuing operations and our future financial results, cash flows, available credit, prospects and liquidity. Except as required by law, the Company does not undertake to publicly update or revise its forward-looking statements, whether as a result of new information, future events or otherwise. View source version on Contacts Investor Relations Contact Gary Schnierow, Vice President, Investor Relations & Corporate Financegarys@ Media Relations Contact pr@ Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
3 hours ago
- Yahoo
National Fuel Increases Dividend Rate for 55th Consecutive Year
WILLIAMSVILLE, N.Y., June 12, 2025 (GLOBE NEWSWIRE) -- Today, the National Fuel Gas Company ("National Fuel" or the "Company") (NYSE: NFG) Board of Directors approved a 3.9% increase in the dividend on the Company's common stock, raising the quarterly rate from 51.5 cents per share as approved in June 2024 to 53.5 cents per share for an annual rate of $2.14 per share. National Fuel has paid dividends for 123 consecutive years and has increased its annual dividend for 55 straight years. This dividend is payable July 15, 2025, to stockholders of record at the close of business on June 30, 2025. The Company has approximately 90.4 million shares of common stock outstanding. It has no preferred stock outstanding. National Fuel is a diversified energy company headquartered in Western New York that operates an integrated collection of natural gas assets across four business segments: Exploration & Production, Pipeline & Storage, Gathering, and Utility. Additional information about National Fuel is available at CONTACT: Investor Contact: Natalie Fischer | 716-857-7315 Media Contact: Karen Merkel | 716-857-7654Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
